Hemiacetal Ester Side Chains as a Mild Protecting Group for Carboxylic Acids in Polycarbonate Backbones.

Macromol Rapid Commun

Institute of Functional Materials and Biofabrication, Department of Chemistry and Pharmacy, Julius-Maximilians-Universität Würzburg, 97070, Würzburg, Germany.

Published: February 2025

Hemiacetal esters are versatile functional groups known for their unique ability to degrade under mild conditions such as exposure to water, alcohols, organic acids, or heat. In this study, hemiacetal esters are introduced as mild, transient protecting groups for carboxylic acids along polycarbonate backbones. A six-membered cyclic carbonate monomer is synthesized by reacting ethyl vinyl ether with a carboxylic acid precursor, demonstrating high efficiency and stability under nucleophilic polymerization conditions. Potential susceptibilities of the hemiacetal esters to transacetalization reactions do not occur under these polymerization conditions. Instead, well-defined homo and PEG-based block copolymers are obtained with narrow molecular weight distributions and preserved hemiacetal ester functionalities. These labile side chain groups enabled facile deprotection, yielding polycarbonates with free carboxylic acids, holding significant potential for applications in drug delivery, sustainable polymers, and advanced functional materials.

Download full-text PDF

Source
http://dx.doi.org/10.1002/marc.202500082DOI Listing

Publication Analysis

Top Keywords

carboxylic acids
12
hemiacetal esters
12
hemiacetal ester
8
acids polycarbonate
8
polycarbonate backbones
8
polymerization conditions
8
hemiacetal
5
ester side
4
side chains
4
chains mild
4

Similar Publications

Introduction: Older patients with acute myeloid leukemia (AML) respond poorly to standard induction therapy. DNA methyltransferases (DNMTs) and histone-deacetylases (HDACs) are key regulators of gene expression in cells and have been investigated as important therapeutic targets. However, their effects remains unclear as induction therapy for AML.

View Article and Find Full Text PDF

Selective Transformation of Biomass and the Derivatives for Aryl Compounds and Hydrogen via Visible-Light-Induced Radicals.

Acc Chem Res

March 2025

Frontier Institute of Science and Technology and State Key Laboratory of Multi-phase Flow in Power Engineering, Xi'an Jiaotong University, Xi'an 712046, China.

ConspectusFor sustainable development, exploring renewable resources is an urgent priority. Nonfood biomass, one of the largest renewable resources on Earth, primarily comprises three key components: lignin (ca. 15-30%), cellulose (ca.

View Article and Find Full Text PDF

During anaerobic digestion (AD) of lignocellulose- and protein-rich substrates known to contain a high load of aromatic compounds, various undesired intermediates can arise, which can accumulate and cause serious disturbances during the cascade-like AD process. The phenyl acids phenyl-acetic-(PAA), phenyl-propionic-(PPA), and phenyl-butyric acid (PBA) are such intermediates suspected to negatively affect the microbial community, resulting in a decreased biogas yield. In the present study, the impact of PAA, PPA, and PBA on the metabolism of CO reducing methanogens was investigated.

View Article and Find Full Text PDF

Sodium acetate (NaA) has demonstrated potential in improving non-alcoholic fatty liver disease (NAFLD) by targeting hepatocytes and Kupffer cells. However, its clinical application is hindered by low oral bioavailability and insufficient liver concentrations. Liposomes, with their capacity to encapsulate water-soluble drugs and be surface-modified, offer a promising solution for targeted oral drug delivery.

View Article and Find Full Text PDF

: Non-small-cell lung cancer (NSCLC) accounts for approximately 85% of all lung cancer cases and is a leading cause of morbidity and mortality worldwide. Between 35% and 65% of NSCLC patients experience nutritional problems or malnutrition, which significantly affects their prognosis and quality of life. This study aims to describe the nutritional status and body composition of NSCLC patients treated with osimertinib, an oral tyrosine kinase inhibitor, while also assessing the prevalence of sarcopenia, presarcopenia, and dynapenia.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!